Avidity Partners Management LP
- SEC CIK
- 0001791827
- 最新申報
- 2026/8/14
2021 年第 3 季持倉
持倉截至 2021/9/30，2021/11/15 申報。只含多頭部位，變化是跟 2021 年第 2 季比股數。
- 持股檔數
- 103
- 較 2021 年第 2 季 −9
- 總值
- $39.2 億
- 較 2021 年第 2 季 +$2.23 億 (+6.0%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| MRTXMirati Therapeutics, Inc. | COM | 1,062,400 | $1.88 億 | 4.8% | +309,400+41.1% | 加碼 | 歷史 |
| ARVNArvinas, Inc. | COM | 2,234,700 | $1.84 億 | 4.7% | +380,700+20.5% | 加碼 | 歷史 |
| ABBVAbbVie Inc. | Stock | 1,613,200 | $1.74 億 | 4.4% | +128,800+8.7% | 加碼 | 歷史 |
| VRTXVertex Pharmaceuticals Inc | Stock | 926,400 | $1.68 億 | 4.3% | −23,600−2.5% | 減碼 | 歷史 |
| ZNTLZentalis Pharmaceuticals, Inc. | COM | 2,493,800 | $1.66 億 | 4.2% | +333,800+15.5% | 加碼 | 歷史 |
| AVTRAvantor, Inc. | COM | 3,247,700 | $1.33 億 | 3.4% | +67,700+2.1% | 加碼 | 歷史 |
| BHVNBiohaven Ltd. | COM | 934,200 | $1.30 億 | 3.3% | +51,700+5.9% | 加碼 | 歷史 |
| SNDXSyndax Pharmaceuticals Inc | COM | 4,823,400 | $9,218 萬 | 2.3% | +208,400+4.5% | 加碼 | 歷史 |
| REGNRegeneron Pharmaceuticals, Inc. | COM | 152,300 | $9,217 萬 | 2.3% | +152,300 | 新進 | 歷史 |
| SGENSeagen Inc. | COM | 537,000 | $9,118 萬 | 2.3% | −103,000−16.1% | 減碼 | 歷史 |
| HZNPHorizon Therapeutics Public Ltd Co | SHS | 826,000 | $9,048 萬 | 2.3% | +258,000+45.4% | 加碼 | 歷史 |
| BPMCBlueprint Medicines Corp | COM | 832,000 | $8,554 萬 | 2.2% | +268,800+47.7% | 加碼 | 歷史 |
| AZNAstraZeneca PLC | SPONSORED ADR | 1,412,000 | $8,481 萬 | 2.2% | +1,412,000 | 新進 | 歷史 |
| NBIXNeurocrine Biosciences Inc | Stock | 848,900 | $8,142 萬 | 2.1% | +167,900+24.7% | 加碼 | 歷史 |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 427,000 | $8,062 萬 | 2.1% | +232,000+119.0% | 加碼 | 歷史 |
| LLYEli Lilly & Co | Stock | 330,000 | $7,625 萬 | 1.9% | −235,500−41.6% | 減碼 | 歷史 |
| NUVBNuvation Bio Inc. | COM CL A | 7,263,488 | $7,220 萬 | 1.8% | +297,112+4.3% | 加碼 | 歷史 |
| NTRANatera, Inc. | COM | 638,700 | $7,118 萬 | 1.8% | +202,700+46.5% | 加碼 | 歷史 |
| HOLXHologic Inc | COM | 945,400 | $6,978 萬 | 1.8% | −263,400−21.8% | 減碼 | 歷史 |
| BAXBaxter International Inc | Stock | 862,000 | $6,933 萬 | 1.8% | +862,000 | 新進 | 歷史 |
| ARNAArena Pharmaceuticals Inc | COM NEW | 1,139,000 | $6,783 萬 | 1.7% | +196,000+20.8% | 加碼 | 歷史 |
| ISEEIVERIC bio, Inc. | COM | 4,100,000 | $6,658 萬 | 1.7% | +2,699,990+192.9% | 加碼 | 歷史 |
| UTHRUnited Therapeutics Corp | COM | 351,000 | $6,479 萬 | 1.7% | +114,600+48.5% | 加碼 | 歷史 |
| STVNStevanato Group S.p.A. | ORD SHS | 2,541,893 | $6,434 萬 | 1.6% | +2,541,893 | 新進 | 歷史 |
| SHCSotera Health Co | COM | 2,378,000 | $6,219 萬 | 1.6% | +468,000+24.5% | 加碼 | 歷史 |
| IDYAIDEAYA Biosciences, Inc. | COM | 2,437,000 | $6,212 萬 | 1.6% | +367,000+17.7% | 加碼 | 歷史 |
| CRBUCaribou Biosciences, Inc. | COM | 2,474,067 | $5,906 萬 | 1.5% | +2,474,067 | 新進 | 歷史 |
| CTLTCatalent, Inc. | COM | 398,000 | $5,296 萬 | 1.4% | −142,000−26.3% | 減碼 | 歷史 |
| GRTSGritstone bio, Inc. | COM | 4,457,831 | $4,815 萬 | 1.2% | +2,335,767+110.1% | 加碼 | 歷史 |
| LEGNLegend Biotech Corp | SPONSORED ADS | 894,000 | $4,520 萬 | 1.2% | +269,000+43.0% | 加碼 | 歷史 |
| OCDXOrtho Clinical Diagnostics Holdings plc | ORD SHS | 2,398,000 | $4,432 萬 | 1.1% | +2,398,000 | 新進 | 歷史 |
| PFEPfizer Inc | Stock | 1,026,800 | $4,416 萬 | 1.1% | +1,026,800 | 新進 | 歷史 |
| ARWRArrowhead Pharmaceuticals, Inc. | COM | 673,700 | $4,206 萬 | 1.1% | +569,700+547.8% | 加碼 | 歷史 |
| STTKShattuck Labs, Inc. | COM | 2,025,000 | $4,127 萬 | 1.1% | +84,800+4.4% | 加碼 | 歷史 |
| RAREUltragenyx Pharmaceutical Inc. | COM | 455,000 | $4,104 萬 | 1.0% | +455,000 | 新進 | 歷史 |
| IMCRImmunocore Holdings plc | ADS | 1,095,600 | $4,061 萬 | 1.0% | +494,600+82.3% | 加碼 | 歷史 |
| Avidity Biosciences, Inc.05370A108 | COM | 1,645,000 | $4,052 萬 | 1.0% | +1,645,000 | 新進 | – |
| IOVAIovance Biotherapeutics, Inc. | COM | 1,462,200 | $3,606 萬 | 0.9% | +1,462,200 | 新進 | 歷史 |
| INSMINSMED Inc | COM PAR $.01 | 1,292,000 | $3,558 萬 | 0.9% | +141,950+12.3% | 加碼 | 歷史 |
| EXASExact Sciences Corp | COM | 369,000 | $3,522 萬 | 0.9% | −221,000−37.5% | 減碼 | 歷史 |
| CMPSCOMPASS Pathways plc | SPONSORED ADS | 1,162,000 | $3,471 萬 | 0.9% | +162,000+16.2% | 加碼 | 歷史 |
| ATECAlphatec Holdings, Inc. | COM NEW | 2,786,000 | $3,396 萬 | 0.9% | +165,000+6.3% | 加碼 | 歷史 |
| NTLAIntellia Therapeutics, Inc. | COM | 251,000 | $3,367 萬 | 0.9% | −129,000−33.9% | 減碼 | 歷史 |
| NBPNovaBridge Biosciences | SPONSORED ADS | 454,000 | $3,291 萬 | 0.8% | −275,000−37.7% | 減碼 | 歷史 |
| SPNESeaSpine Holdings Corp | COM | 1,943,000 | $3,056 萬 | 0.8% | +418,002+27.4% | 加碼 | 歷史 |
| Bellus Health Inc New07987C204 | COM NEW | 4,942,000 | $3,034 萬 | 0.8% | +692,000+16.3% | 加碼 | – |
| KYMRKymera Therapeutics, Inc. | COM | 514,500 | $3,022 萬 | 0.8% | +514,500 | 新進 | 歷史 |
| CYTCyteir Therapeutics, Inc. | COM | 1,683,441 | $2,954 萬 | 0.8% | −124,953−6.9% | 減碼 | 歷史 |
| ALTAltimmune, Inc. | COM NEW | 2,167,900 | $2,452 萬 | 0.6% | +2,167,900 | 新進 | 歷史 |
| VIRVir Biotechnology, Inc. | COM | 515,000 | $2,241 萬 | 0.6% | +353,000+217.9% | 加碼 | 歷史 |
| ALPNAlpine Immune Sciences, Inc. | COM | 1,932,000 | $2,061 萬 | 0.5% | +437,000+29.2% | 加碼 | 歷史 |
| EPIXESSA Pharma Inc. | COM NEW | 2,450,000 | $1,960 萬 | 0.5% | −300,000−10.9% | 減碼 | 歷史 |
| ACETAdicet Bio, Inc. | COM | 2,419,600 | $1,897 萬 | 0.5% | +169,100+7.5% | 加碼 | 歷史 |
| IPSCCentury Therapeutics, Inc. | COM | 739,269 | $1,860 萬 | 0.5% | −264,253−26.3% | 減碼 | 歷史 |
| SIBNSI-BONE, Inc. | COM | 831,200 | $1,780 萬 | 0.5% | +256,200+44.6% | 加碼 | 歷史 |
| SANASana Biotechnology, Inc. | COM | 774,644 | $1,745 萬 | 0.4% | −3,953−0.5% | 減碼 | 歷史 |
| PATHUiPath, Inc. | Stock | 319,000 | $1,678 萬 | 0.4% | +19,000+6.3% | 加碼 | 歷史 |
| Field Trip Health Ord31656R102 | COM | 3,581,000 | $1,644 萬 | 0.4% | +3,581,000 | 新進 | – |
| LFSTLifeStance Health Group, Inc. | COM | 1,000,000 | $1,450 萬 | 0.4% | −100,000−9.1% | 減碼 | 歷史 |
| PHASPhaseBio Pharmaceuticals Inc | COM | 4,405,000 | $1,370 萬 | 0.3% | +90,000+2.1% | 加碼 | 歷史 |
| WGSGeneDx Holdings Corp. | COMMON STOCK | 1,660,000 | $1,260 萬 | 0.3% | +1,660,000 | 新進 | 歷史 |
| GHRSGH Research PLC | ORDINARY SHARES | 560,000 | $1,235 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| LENZLENZ Therapeutics, Inc. | COM | 748,995 | $1,228 萬 | 0.3% | +13,495+1.8% | 加碼 | 歷史 |
| ACIUAC Immune SA | SHS | 1,739,600 | $1,167 萬 | 0.3% | +155,600+9.8% | 加碼 | 歷史 |
| SCYXScynexis Inc | COM NEW | 2,060,000 | $1,092 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| HOWLWerewolf Therapeutics, Inc. | COM | 625,120 | $1,073 萬 | 0.3% | −25,145−3.9% | 減碼 | 歷史 |
| SSentinelOne, Inc. | CL A | 200,000 | $1,071 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| HARPHarpoon Therapeutics, Inc. | COM | 1,190,600 | $940.6 萬 | 0.2% | −309,400−20.6% | 減碼 | 歷史 |
| ESMTEngageSmart, Inc. | COMMON STOCK | 275,000 | $936.7 萬 | 0.2% | +275,000 | 新進 | 歷史 |
| ACADAcadia Pharmaceuticals Inc | COM | 550,000 | $913.6 萬 | 0.2% | −390,000−41.5% | 減碼 | 歷史 |
| ORTXOrchard Therapeutics plc | ADS | 3,836,798 | $882.5 萬 | 0.2% | +55,000+1.5% | 加碼 | 歷史 |
| CMAXCareMax, Inc. | COM CL A | 827,402 | $799.3 萬 | 0.2% | +10,000+1.2% | 加碼 | 歷史 |
| ZETAZeta Global Holdings Corp. | CL A | 1,300,000 | $761.8 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| TILInstil Bio, Inc. | COM | 408,140 | $729.6 萬 | 0.2% | +8,140+2.0% | 加碼 | 歷史 |
| GLUEMonte Rosa Therapeutics, Inc. | COM | 300,000 | $668.4 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| ONCSOncosec Medical Inc | COM | 2,945,000 | $627.3 萬 | 0.2% | +145,000+5.2% | 加碼 | 歷史 |
| TRMLTourmaline Bio, Inc. | COM | 455,000 | $617.0 萬 | 0.2% | +18,637+4.3% | 加碼 | 歷史 |
| XLRNAcceleron Pharma Inc | COM | 35,000 | $602.4 萬 | 0.2% | −323,500−90.2% | 減碼 | 歷史 |
| KROSKeros Therapeutics, Inc. | COM | 145,100 | $574.0 萬 | 0.1% | +145,100 | 新進 | 歷史 |
| TCRTAlaunos Therapeutics, Inc. | COM | 3,000,000 | $546.0 萬 | 0.1% | +3,000,000 | 新進 | 歷史 |
| Medicus Sciences AcquisitionG5960S108 | CL A SHS | 520,000 | $507.0 萬 | 0.1% | 00.0% | 不變 | – |
| ARYDARYA Sciences Acquisition Corp IV | CL A | 500,000 | $502.5 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| BCLS Acquisition CorpG0904B105 | COM CL A | 500,000 | $498.0 萬 | 0.1% | 00.0% | 不變 | – |
| Dynamics Special Purpose Cor268010105 | CLASS A COM | 500,000 | $497.0 萬 | 0.1% | 00.0% | 不變 | – |
| HYPRHyperfine, Inc. | CL A SHS | 500,000 | $495.0 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| Panacea Acquisition Corp. IIG6882C106 | CL A SHS | 500,000 | $488.5 萬 | 0.1% | 00.0% | 不變 | – |
| SLGCSomaLogic, Inc. | CLASS A COM | 330,000 | $408.9 萬 | 0.1% | +330,000 | 新進 | 歷史 |
| OBIOOrchestra BioMed Holdings, Inc. | ORD SHS | 400,000 | $395.6 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| MLTXMoonLake Immunotherapeutics | COM CL A | 400,000 | $394.0 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| SNCEScience 37 Holdings, Inc. | COM | 400,000 | $392.0 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| TNGXTango Therapeutics, Inc. | COM | 300,000 | $387.9 萬 | 0.1% | +300,000 | 新進 | 歷史 |
| ZLABZai Lab Ltd | ADR | 35,600 | $375.2 萬 | 0.1% | −64,400−64.4% | 減碼 | 歷史 |
| NAUTNautilus Biotechnology, Inc. | COM | 600,000 | $368.4 萬 | 0.1% | −525,000−46.7% | 減碼 | 歷史 |
| SGHTSight Sciences, Inc. | COM | 145,189 | $329.6 萬 | 0.1% | +145,189 | 新進 | 歷史 |
| ATAIAtai Beckley N.V. | SHS | 218,730 | $323.5 萬 | 0.1% | −132,257−37.7% | 減碼 | 歷史 |
| KZRKezar Life Sciences, Inc. | COM | 260,000 | $224.6 萬 | 0.1% | +260,000 | 新進 | 歷史 |
| AKLIAkili, Inc. | CLASS A ORD SHS | 200,000 | $199.0 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| DNABSocial Capital Suvretta Holdings Corp. II | CLASS A ORD SHS | 200,000 | $197.6 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| DNADSocial Capital Suvretta Holdings Corp. IV | CLASS A ORD SHS | 200,000 | $196.2 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| PROKProkidney Corp. | CLASS A ORD SHS | 200,000 | $196.0 萬 | <0.1% | 00.0% | 不變 | 歷史 |
選擇權（2 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
| 證券 | 類別 | 賣權 | 買權 |
|---|---|---|---|
| State Street SPDR S&P Biotech ETF78464A870 | ETF | – | $3.80 億 |
| XLRNAcceleron Pharma Inc | COM | – | $2.11 億 |
2021 年第 2 季之後清倉（31 檔）
2021 年第 2 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2021 年第 2 季股數 | 2021 年第 2 季市值 | 2021 年第 2 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| MRVIMaravai Lifesciences Holdings, Inc. | COM CL A | 2,963,545 | $1.24 億 | 3.3% | 歷史 |
| MDTMedtronic plc | Stock | 535,000 | $6,641 萬 | 1.8% | 歷史 |
| BIIBBiogen Inc. | COM | 183,900 | $6,368 萬 | 1.7% | 歷史 |
| NEONeogenomics Inc | COM NEW | 1,367,000 | $6,175 萬 | 1.7% | 歷史 |
| CNCCentene Corp | Stock | 751,200 | $5,479 萬 | 1.5% | 歷史 |
| BBIOBridgeBio Pharma, Inc. | COM | 673,400 | $4,105 萬 | 1.1% | 歷史 |
| Trillium Therapeutics Inc.89620X506 | COM NEW | 4,105,000 | $3,982 萬 | 1.1% | – |
| CAHCardinal Health Inc | Stock | 654,200 | $3,735 萬 | 1.0% | 歷史 |
| KDMNKadmon Holdings, Inc. | COM | 9,294,600 | $3,597 萬 | 1.0% | 歷史 |
| DVAXDynavax Technologies Corp | COM NEW | 3,400,000 | $3,349 萬 | 0.9% | 歷史 |
| ALDXAldeyra Therapeutics, Inc. | COM | 1,450,000 | $1,643 萬 | 0.4% | 歷史 |
| SYNHSyneos Health, Inc. | CL A | 175,000 | $1,566 萬 | 0.4% | 歷史 |
| PRTAProthena Corp Public Ltd Co | SHS | 182,000 | $935.7 萬 | 0.3% | 歷史 |
| CRDFCardiff Oncology, Inc. | COM | 1,395,000 | $927.7 萬 | 0.3% | 歷史 |
| MNDYmonday.com Ltd. | SHS | 40,000 | $894.4 萬 | 0.2% | 歷史 |
| DOCSDoximity, Inc. | CL A | 150,000 | $873.0 萬 | 0.2% | 歷史 |
| ESPREsperion Therapeutics, Inc. | COM | 400,000 | $846.0 萬 | 0.2% | 歷史 |
| PHVSPharvaris N.V. | COM | 400,000 | $745.2 萬 | 0.2% | 歷史 |
| CM Life Sciences Inc18978W109 | COM CL A | 525,000 | $735.5 萬 | 0.2% | – |
| DNLIDenali Therapeutics Inc. | COM | 86,100 | $675.4 萬 | 0.2% | 歷史 |
| FIGSFIGS, Inc. | CL A | 100,000 | $501.0 萬 | 0.1% | 歷史 |
| CELCCelcuity Inc. | COM | 200,000 | $480.0 萬 | 0.1% | 歷史 |
| CFLTConfluent, Inc. | CLASS A COM | 100,000 | $475.0 萬 | 0.1% | 歷史 |
| CM Life Sciences II Inc125842203 | UNIT 02/25/2028 | 330,000 | $443.9 萬 | 0.1% | – |
| Walkme LtdM97628107 | ORD SHS | 150,000 | $438.9 萬 | 0.1% | – |
| BCTG Acquisition Corp05492W103 | COM | 300,000 | $341.4 萬 | 0.1% | – |
| TKNOAlpha Teknova, Inc. | COM | 100,000 | $237.3 萬 | 0.1% | 歷史 |
| FLYWFlywire Corp | COM VTG | 50,000 | $183.7 萬 | <0.1% | 歷史 |
| CLVSClovis Oncology, Inc. | COM | 271,726 | $157.6 萬 | <0.1% | 歷史 |
| OMICSingular Genomics Systems, Inc. | COM | 50,000 | $137.4 萬 | <0.1% | 歷史 |
| NPCENeuroPace Inc | COM | 40,000 | $95.2 萬 | <0.1% | 歷史 |